Classys
Classys is a South Korean medical device company developing non-invasive skin-care and aesthetic treatment technologies.
Last updated October 12, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Classys Inc. is a South Korean medical device company headquartered in Seoul and focused on non-invasive skin-care and aesthetic-treatment technologies. The company was founded in 2007 by Jung Sung-jae, a dermatologist who established the business while continuing to work in clinical practice. Its origins therefore lie at the intersection of dermatology and medical-device development, with the company concentrating on technologies intended for aesthetic and skin-care procedures rather than conventional hospital equipment. Classys developed its business around devices used in non-invasive or minimally invasive aesthetic treatment settings. The available reference material does not identify individual product names, technical platforms, regulatory jurisdictions, or detailed revenue by geography, so the brand is best characterized at the company level: it supplies professional medical and aesthetic equipment designed for skin-care and appearance-related treatments. Its customer and distribution base extends beyond South Korea, and the company states that its devices are exported to more than 60 countries as of 2025. A major corporate turning point came in 2017, when Classys became publicly traded on the KOSDAQ through a merger with a special-purpose acquisition company. This transaction provided the company with a public-market structure while it continued operating in the medical-aesthetics sector. Another significant change occurred in 2022, when Bain Capital Private Equity acquired a 60.84% stake in Classys for 670 billion Korean won. The transaction made Bain the controlling shareholder while leaving Classys as an operating medical-device business. Classys is consequently positioned as a specialist aesthetic-medical-device company with Korean origins and an international export footprint. Its brand identity is associated with dermatologist-led product development, non-invasive treatment technologies, and professional use in skin-care and aesthetic practices. The supplied sources do not provide enough information to describe its current executive team, named device families, marketing campaigns, detailed financial performance, or post-acquisition corporate structure without speculation.
History
Classys was founded in 2007 in South Korea by Jung Sung-jae, a dermatologist. The company began by developing medical devices with an emphasis on skin care and aesthetic treatment. Its founder's clinical background shaped the company's specialization in technologies intended for non-invasive procedures and professional dermatology or aesthetic settings. During its early development, Classys established itself as a specialist rather than a diversified medical-equipment manufacturer. The available source material does not provide a detailed account of its early product launches, manufacturing sites, regulatory approvals, or distribution partnerships, but it identifies skin-care and aesthetic medical devices as the core of the business. In 2017, Classys became a public company through a merger with a special-purpose acquisition company and was listed on the KOSDAQ. The transaction marked an important financing and governance milestone, giving the company access to the Korean public market while it continued to focus on medical-aesthetic technology. The next major ownership transition occurred in 2022. Bain Capital Private Equity acquired 60.84% of Classys for 670 billion Korean won. This transaction gave Bain a controlling position in the company and represented a significant change in Classys's shareholder structure. The available references do not specify whether the founder retained an operating role after the transaction or describe subsequent board and management changes. By 2025, Classys was described as exporting its devices to more than 60 countries. This indicates that the company had developed an international commercial presence beyond its South Korean base. Its business remains centered on non-invasive skin-care and aesthetic-treatment technologies, although the supplied sources do not name specific device families or provide enough information to document product-by-product development. Classys is therefore best understood as a South Korean, dermatologist-founded medical-device company with a global export footprint and private-equity-controlled ownership.
- 2025
International exports exceed 60 countries
[1]Classys was reported to export its devices to more than 60 countries.
- 2022
Bain Capital acquires controlling stake
[1]Bain Capital Private Equity acquired a 60.84% stake in Classys for 670 billion Korean won.
- 2017
KOSDAQ listing through SPAC merger
[1]Classys became publicly listed on the KOSDAQ through a merger with a special-purpose acquisition company.
- 2007
Company founded
[1]Dermatologist Jung Sung-jae founded Classys in South Korea and began developing medical devices focused on skin care.
Products and positioning
A specialist medical-device brand focused on dermatologist-led, non-invasive skin-care and aesthetic-treatment technologies for professional markets.
Aesthetic medical devices
Non-invasive skin-care and aesthetic-treatment devices
Classys develops professional medical devices for non-invasive skin-care and aesthetic treatments. The reference material identifies this category as the company's core business but does not provide individual product names, launch dates, treatment indications, or technical specifications.
Brand decisions
2022
Bain Capital Private Equity investment and control acquisitionM&ABackground
Classys underwent a major ownership change after Bain Capital Private Equity pursued a controlling investment.
Action taken
Bain Capital Private Equity acquired 60.84% of Classys for 670 billion Korean won.
Aftermath
Bain became the controlling shareholder of Classys. The available source does not document subsequent management or strategy changes.
Acquisition consideration. 670 billion Korean won (2022)
2017
Public listing through special-purpose acquisition company mergerM&ABackground
Classys pursued a public-market listing as part of its corporate development in the medical-device sector.
Action taken
The company merged with a special-purpose acquisition company and became listed on the KOSDAQ.
Aftermath
The transaction established Classys as a publicly traded Korean medical-device company.
Recent events
- 2025
Classys exports devices to more than 60 countries[1]
Other
Classys is reported to export its medical devices to more than 60 countries, reflecting an international operating footprint.
- 2022
Bain Capital Private Equity acquires controlling stake in Classys[1]
M&A
Bain Capital Private Equity acquired a 60.84% stake in Classys for 670 billion Korean won, becoming its controlling shareholder.
- 2017
Classys becomes publicly listed on KOSDAQ through SPAC merger[1]
M&A · Other
Classys entered the KOSDAQ market through a merger with a special-purpose acquisition company.
- 2007
Classys founded by dermatologist Jung Sung-jae[1]
Other
Jung Sung-jae established Classys in South Korea while working as a dermatologist, beginning the company's development of medical devices for skin care and aesthetic treatment.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/classys · Editorial policy · How profiles are compiled